| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 27.97 Billion | USD 47.43 Billion | 6.1% | 2024 |
FrequentlyAsked Questions
The global assisted reproductive technology market is expected to grow due to rising infertility rates, increasing awareness and acceptance of treatments like IVF, technological advancements, and supportive government initiatives in reproductive healthcare.
According to a study, the global assisted reproductive technology market size was worth around USD 27.97 Billion in 2024 and is expected to reach USD 47.43 Billion by 2034.
The global assisted reproductive technology market is expected to grow at a CAGR of 6.1% during the forecast period.
North America is expected to dominate the assisted reproductive technology market over the forecast period.
Leading players in the global assisted reproductive technology market include Fujifilm Holdings Corporation (Irvine Scientific Sales Company Inc), Oxford Gene Technology, Cook Medical Inc, Genea Biomedx, Millendo Therapeutics Inc, Merck KGaA (EMD Serono Inc), The Cooper Companies Inc (CooperSurgical Inc), Progyny Inc, Vitrolife AB,, among others.
The report explores crucial aspects of the assisted reproductive technology market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients